1. Home
  2. AXSM vs CNX Comparison

AXSM vs CNX Comparison

Compare AXSM & CNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • CNX
  • Stock Information
  • Founded
  • AXSM 2012
  • CNX 1860
  • Country
  • AXSM United States
  • CNX United States
  • Employees
  • AXSM N/A
  • CNX N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • CNX Oil & Gas Production
  • Sector
  • AXSM Health Care
  • CNX Energy
  • Exchange
  • AXSM Nasdaq
  • CNX Nasdaq
  • Market Cap
  • AXSM 4.2B
  • CNX 5.5B
  • IPO Year
  • AXSM 2015
  • CNX 1999
  • Fundamental
  • Price
  • AXSM $84.60
  • CNX $30.30
  • Analyst Decision
  • AXSM Strong Buy
  • CNX Hold
  • Analyst Count
  • AXSM 14
  • CNX 11
  • Target Price
  • AXSM $125.54
  • CNX $29.09
  • AVG Volume (30 Days)
  • AXSM 893.5K
  • CNX 3.4M
  • Earning Date
  • AXSM 02-18-2025
  • CNX 01-30-2025
  • Dividend Yield
  • AXSM N/A
  • CNX N/A
  • EPS Growth
  • AXSM N/A
  • CNX N/A
  • EPS
  • AXSM N/A
  • CNX 3.15
  • Revenue
  • AXSM $338,457,000.00
  • CNX $1,369,239,000.00
  • Revenue This Year
  • AXSM $44.77
  • CNX $8.77
  • Revenue Next Year
  • AXSM $67.70
  • CNX $20.49
  • P/E Ratio
  • AXSM N/A
  • CNX $9.64
  • Revenue Growth
  • AXSM 51.47
  • CNX N/A
  • 52 Week Low
  • AXSM $64.11
  • CNX $19.07
  • 52 Week High
  • AXSM $105.00
  • CNX $41.93
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 43.66
  • CNX 28.66
  • Support Level
  • AXSM $79.19
  • CNX $29.49
  • Resistance Level
  • AXSM $87.53
  • CNX $31.47
  • Average True Range (ATR)
  • AXSM 4.37
  • CNX 1.37
  • MACD
  • AXSM -0.02
  • CNX -0.61
  • Stochastic Oscillator
  • AXSM 61.27
  • CNX 8.52

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About CNX CNX Resources Corporation

CNX Resources Corp is an independent low carbon intensity natural gas and midstream company engaged in the exploration, development, production and acquisition of natural gas properties in the Appalachian Basin. The company's operating segment include Shale and Coalbed Methane. It generates maximum revenue from the Shale segment. It also has other segment that includes nominal shallow oil and gas production.

Share on Social Networks: